We recently isolated the RhoH/TTF gene by its fusion to the LAZ3/BCL6 gene, in a non-Hodgkin's lymphoma (NHL) cell line, which bore a t(3;4)(q27;p11 ± 13) translocation. This gene encodes a novel Rho GTP-binding protein and is speci®cally expressed in hematopoietic tissues. We made its precise mapping at band 4p13, and described its partial genomic structure. Using¯uorescence in situ hybridization and molecular analyses, we report here on the rearrangement of the RhoH/TTF gene, at band 4p13, in four cases of NHL with t(3;4)(q27;p13) translocation and its fusion to the LAZ3/BCL6 gene at band 3q27, in three of these cases. RT ± PCR analysis of two cases allowed the detection of variable fusion transcripts emerging from the rearranged alleles, and in one case, a deregulated expression of both RhoH/TTF and LAZ3/BCL6 genes, by promoter substitution, was observed. We also show here another rearrangement of the RhoH/TTF gene in a patient with multiple myeloma and t(4;14)(p13;q32) translocation, with breakage within the IGH gene. It is the ®rst report which describes the recurrent chromosomal alteration of a GTP-binding protein encoding gene, in patients with hematopoietic malignancies.
Introduction
Recurrent reciprocal chromosome translocations involving a number of oncogene loci are found in several types of non-Hodgkin's lymphoma (NHL) (Rabbitts, 1994) . Two NHL subtypes, follicular lymphoma and Burkitt's lymphoma, are associated with t(14;18) (q32;q21) and t(8;14)(q24;q32) translocations which involve the BCL2 (Tsujimoto et al., 1984) and MYC (Manolova et al., 1979) oncogenes, at bands 18q21 and 8q24, respectively. Deregulated over-expression of both BCL2 and MYC oncogenes results from their fusion with immunoglobulin (IG) genes (at band 14q32). In mantle cell lymphoma, the t(11;14)(q13;q32) translocation speci®cally induces over-expression of the cyclin D1 (PRAD1) gene, by juxtaposition with the IG gene (Motokura et al., 1991) . Translocations which involve band 3q27 are the third most common speci®c abnormalities in NHL (Bastard et al., 1994) and are associated with disruption of a zinc-®nger encoding gene, LAZ3 or BCL-6 (Kerckaert et al., 1993; Ye et al., 1993) . The LAZ3 (BCL6) gene encodes a sequencespeci®c BTB-POZ transcriptional inhibitor , and might be implicated in chromatin modelling and gene regulation via its BTB/POZ protein-protein interaction domain . LAZ3 exerts its transcriptional repressing eect by the recruitment of both the SMRT co-repressor (Dhordain et al., 1997) and a SMRT/mSIN3A/Histone deacetylase containing complex (Dhordain et al., 1998; Wong and Privalsky, 1998 ). The LAZ3 gene shows a speci®c and high expression in germinal-center (GC) B cells (Cattoretti et al., 1995; Bajalica-Lagerkrantz et al., 1997) and controls GC formation and Th2-type in¯ammation (Dent et al., 1997; Ye et al., 1997) .
We have recently discovered a new member of the Rho protein subfamily, designated TTF (for Translocation Three Four), which was later renamed RhoH. The RhoH/TTF gene has been identi®ed by its fusion to the LAZ3 gene in a t(3;4)(q27;p11 ± 13) translocation present in a non-Hodgkin's lymphoma cell line, VAL (Dallery et al., 1995) . The RhoH/TTF protein sequence possesses many Rho-hallmarks and phylogenetic analysis have shown that the RhoH/TTF product de®nes a new group within the Rho subfamily, distinct from both Rac and Cdc42 groups (Dallery et al., 1995) . Almost all Ras-like genes are ubiquitously expressed. However, the transcription of RhoH/TTF is only observed in hematopoietic tissues (Dallery et al., 1995) . In this regard, this gene is similar to the Rac2 gene (Reibel et al., 1991) . We have recently mapped RhoH/TTF, at band 4p13, by FISH experiments and we have described the partial gene structure, showing one ®rst non-coding exon and a second single coding exon, bearing the entire coding part of the gene (Dallery-Prudhomme et al., 1997) . We have very recently isolated another 5' non-coding exon (called exon 1a) (unpublished results) , but the function of the two 5' non-coding exons (1a, 1b) is not established at this time (work in progress).
We report here on¯uorescence in situ hybridization (FISH) analysis on four cases of NHL which bear a t(3;4)(q27;p13) translocation, and RT ± PCR, Northern blot analyses on two of these cases. Our results show the disruption of the RhoH/TTF gene in the four cases, and its fusion with the LAZ3 gene, at band 3q27, in three of these patients. RT ± PCR analyses of two cases allowed us to show that at least in one case, a consequence of the translocation was a deregulated expression of both RhoH/TTF and LAZ3 genes, by promoter substitution. We also show here that the RhoH/TTF gene is not only the LAZ3 partner in these 4p13 abnormalities, but can also be involved in other chromosome translocation: using a FISH method again, we describe the rearrangement of this gene in one case of multiple myeloma which bears a single translocation, t(4;14)(p13;q32). We demonstrate in this case the IgH gene rearrangement, in the Ca2-Ce region. Our results indicate for the ®rst time the recurrent chromosomal alteration of a GTP-binding protein encoding gene in hematopoietic malignancies.
Results

Cytogenetic findings
Main cytogenetic results of the ®ve patients are summarized in Table 1 . All of the patients showed structural change on 4p13 region: the four NHL patients had t(3;4)(q27;p13) ( Table 1 : patients 1 ± 4) and the multiple myeloma (MM) patient had t(4;14)(p13;q32) (Table 1: patient 5). All NHL caryotypes showed additional abnormalities, including the same t(14;18)(q32;q21) translocation, characteristic of follicular lymphoma in patients 1 ± 4. In patient 3 at least, the t(3;4)(q27;p13) translocation was a secondary event, as this patient had two clones, the ®rst which had a t(14;18) and other abnormalities, and the second which presented the same abnormalities, and also t(3;4). All NHL patients had complete (case 4) or partial (cases 1, 2, 3) monosomy for chromosome 6. Clinical data about the patients with t(3;4) have been recently reported (Daudignon et al., 1999) .
The RhoH/TTF gene is disrupted in all patients with t(3;4) translocation and fuses to the LAZ3 (BCL-6) gene in three cases FISH analysis was ®rst used to detect RhoH/TTF rearrangements (in all of the patients). Figure 1 shows a schematic representation of the RhoH/TTF locus, and indicates the probe which was used in this technique: a combination of three genomic clones encompassing the entire gene (l2V18, l4V3 and l4V5). This probe was previously validated in the mapping of the RhoH/TTF (ARHH) gene (DalleryPrudhomme et al., 1997) . 
*Illustrated in Figure 3 Nonrandom 4p13 rearrangement of the RhoH/TTF gene C Preudhomme et al FISH analysis of the four patients with t(3;4)
The RhoH/TTF probe (labeled in green) was ®rst cohybridized with two centromeric probes, one of chromosome 4 (labeled in orange) and one of chromosome 3 (labeled in green). To validate the FISH assay, metaphase chromosomes prepared from normal blood lymphocytes and from the t(3;4) positive lymphoma cell line, VAL, were initially analysed. As expected, a splitting of the RhoH/TTF signal was observed, in 29 of the 30 metaphases of the VAL cell line which were studied: part of the signal remained on 4p13, and the other part was translocated on the long arm of the derivative chromosome 3 (der 3) (data not shown). By comparison, hybridization of the same probe on metaphases from normal blood lymphocytes revealed only two pairs of green spots on normal chromosomes 4. Figure 2 , part I shows the FISH analysis of lymphoma cells spreads from the four patients with t(3;4), showing the splitting of the RhoH/ TTF signal by the translocation, as observed in the VAL cell line. For each patient, at least ten metaphases with abnormal signals were observed. In a second time, we used the same RhoH/TTF probe in combination with an intragenic LAZ3 probe, to unambiguously demonstrate the fusion between RhoH/TTF and LAZ3 genes, in three of these patients, in a double colour fusion FISH assay. To validate this assay, a mix of the RhoH/TTF and LAZ3 intragenic probes was cohybridized on normal and VAL cell line metaphase spreads, as negative and positive controls, respectively. RT ± PCR and Northern blot analyses on two patients with t(3;4) RNA could be prepared from patients 1 and 3, allowing RT ± PCR and Northern blot experiments.
We searched for deregulated expression of the LAZ3 or/and RhoH/TTF gene as a consequence of the translocation, by detecting the fusion transcripts which emerged from the derivative chromosomes 3 and 4 (der 3 and der 4), using RT ± PCR analysis. RT ± PCR experiments were performed on patients 1 and 3, and on the Raji and VAL cell lines, as negative and positive controls, respectively. Table 2 gives the sequence of all primers used in these PCR experiments, and Figure 3 shows a schematic representation of RhoH/TTF and LAZ3 fusion cDNAs, with the positions of the primers' pairs used, and the PCR results. In patient 1, two fusion transcripts were characterized: (i) a TTF(1a)-LAZ3 transcript, fusing the RhoH/TTF exon 1a to the LAZ3 exon 2 (Figure 3 : assay I, product 1) and (ii) a reciprocal LAZ3-TTF fusion product (assay III), joining the LAZ3 regulatory 5' sequences (exon 1a) to the entire RhoH/ TTF coding part (exon 2). This reciprocal fusion transcript was also present in the VAL cell line, but not in patient 3. The TTF(1a)-LAZ3 fusion transcript was also detected in patient 3 as in the VAL cell line (assay I, product 1). Another TTF-LAZ3 product, fusing RhoH/ TTF exons (1a-1b) together to the LAZ3 exon 2, was present in patient 3 as in the VAL cell line, but was absent in patient 1 (assay I, product 2). Such fusion products with a splice junction between RhoH/TTF exon 1b and LAZ3 exon 2 were also ampli®ed from the RhoH/ TTF exon 1b, in patient 3 as in VAL cell line, but not in patient 1 (assay II). Each PCR assay was con®rmed using other primers' pairs (see Table 2 ), leading to the obtention of identical fusion products. All of the PCR products were sequenced (ABI PRISM 310, Perkin Elmer), and the exact sequences of the corresponding exons and the dierent splice junctions were retrieved ( Figure 3c ). The normal RhoH/TTF and LAZ3 transcripts, emerging from normal or tumor cells, were observed in both patients, as in the VAL and Raji cell lines (data not shown).
Northern blot analysis on total RNAs of patients 1 and 3 (Figure 4 ), allowed to detect in both cases the major 2.2 kb RhoH/TTF transcript (Dallery et al., 1995) . The RhoH/TTF cDNA probe (1.4 kb cDNA, containing exons 1b and 2), detected an additional transcript, about 3.8 kb in size (which is the size of the normal LAZ3 transcript), in patient 3 as in the VAL cell line, but not in patient 1 (Figure 4 ). According to the RT ± PCR data (Figure 3 ), this transcript could correspond to the TTF(1b)-LAZ3 or rather TTF(1a-1b)-LAZ3 fusion RNA, where LAZ3 exon 1a (size: 550 bp) would be replaced by RhoH/TTF exons 1b (size: 250 bp) or 1a-1b (total size: 250+130 bp minimum, as the exact size of exon 1a is unknown).
DNA was prepared from patient 1, allowing in this case detection of the RhoH/TTF gene rearrangement, by Southern blot analysis and LD-PCR experiments, allowing us to precise in this case the location of the breakpoint within the RhoH/TTF gene, between exons 1a and 1b (data not shown), unlike in the VAL cell line which broke between exons 1b and 2 (Dallery et al., 1995) .
The RhoH/TTF gene is rearranged in one case of multiple myeloma with t(4;14)(p13;q32) and breakage of the IgH gene FISH experiments indicating the splitting of the RhoH/ TTF gene in patient 5 with t(4;14) are shown in Figure  5 . Because there was a weak amount of myeloma metaphasic cells in the marrow spreads of this patient, only eight metaphases could be analysed by FISH, among them three had t(4;14) translocation. As in the patients with t(3;4) ( Figure 2, part I) , the RhoH/TTF Figure 1 Schematic representation of the RhoH/TTF locus. Black boxes represent exons. The telomeric and centromeric chromosome orientations (horizontal black arrows) are indicated. The three horizontal black segments represent the genomic clones used to make the probe for FISH experiments. Partial RhoH/TTF structure (exons 1b and 2) was already described (DalleryPrudhomme et al., 1997) . Exon 1a was recently discovered and mapped in the 5' region Oncogene Nonrandom 4p13 rearrangement of the RhoH/TTF gene C Preudhomme et al probe (green signal), was co-hybridized with two centromeric probes, of chromosome 4 (orange signal) and of chromosomes 14/22 (red signal), to metaphase spreads of patient 5. The derivative chromosome 14 exhibited two green spots, showing the splitting of the RhoH/TTF signal, with transfer of part of this signal on the long arm of chromosome 14 (Figure 5a ). Because of cross-link of the centromeric chromosome 14/22 probe (Figure 5a ), a painting probe of chromosome 14q (labeled in orange) was used, to unambiguously identify the derivative chromosome 14. The RhoH/TTF green spots were observed on this derivative chromosome 14 (Figure 5b) , thus con®rming the previous result (Figure 5a ). This rearrangement of the RhoH/TTF gene in patient 5 could be veri®ed by Southern blot experiments (data not shown).
When hybridized to a JH probe, DNA of patient 5 did not reveal a rearrangement within the JH region (data not shown). For this reason, FISH experiments were conducted using three cosmids overlapping three dierent regions on the IgH gene locus, from telomere to centromere: JH-Cm-Cd (cos 3/64), Cg3 (cos Ig6), and Ca2-Ce (cos Ig10). Figure 5c shows the green signals which were obtained, using cosmids 3/64 and Ig6 as a ®rst probe. The presence of a green signal on the derivative chromosome 4 con®rmed that part of chromosome 14q32 was translocated on the short arm of chromosome 4, on three metaphases among the 10 analysed. In addition, the green signal totally disappeared from the derivative chromosome 14, indicating that the breakpoint on chromosome 14q32 was centromeric to the Cg3 region. For this reason, a new hybridization was performed with a second probe containing the three cosmids (Figure 5d ). Three green signals were observed on two other tumor metaphases, indicating that the breakpoint was located either within the Ig10 cosmid, or between Ig6 and Ig10 cosmids. Because of the weak intensity of the green signal observed on the derivative chromosome 14, the breakpoint seemed to be located rather within the Ig10 cosmid, i.e. in the Ca-Ce region. This result con®rmed the breakage of the IgH gene, by t(4;14) translocation, in patient 5.
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Nonrandom 4p13 rearrangement of the RhoH/TTF gene C Preudhomme et al
Discussion
We have reported in this work nonrandom chromosomal rearrangements of the 4p13 region, which were found in NHL (four cases) and in MM (one case), and which always involved at band 4p13 the RhoH/TTF gene. RhoH/TTF rearrangements have been observed using at least three dierent techniques, in three of the ®ve patients (nos 1, 3, 5). Patients 2 and 4 were studied by FISH only, due to a lack of material, but in both cases the quality of the spreads, and the large number of metaphases analysed, allowed us to rule out any artifacts and to arm the presence of the RhoH/TTF gene disruption (Figure 2, part I, b, d ). In addition, we unambiguously demonstrated the fusion of RhoH/TTF and LAZ3 genes in three of the four patients with
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Figure 2 FISH analysis of the four patients with t(3;4). Part I, FISH analysis using as probes: (i) two a-satellite probes, a spectrum orange labeled probe speci®c for chromosome 4 and a spectrum green labeled probe speci®c for chromosome 3 (Vysis, Woodcreek, IL) (ii) a biotin-labeled RhoH/TTF DNA probe, detected with FITC-avidin (white arrows). (a): patient 1, (b): patient 2, (c): patient 3, (d): patient 4. In all cases we could see the green RhoH/TTF spots on the short arm of chromosomes 4, near the centromere. On the derivative chromosome 4 (der 4), the spots were splitted, as part of the signal was transferred onto the telomeric extremity of the long arm of the derivative chromosome 3 (der 3). Part II, double colour fusion FISH assay, using as probes: (i) a mix of the biotinlabeled RhoH/TTF and digoxygenin-labeled intragenic LAZ3 probes, detected with FITC-avidin and rhodamin antidigoxygenin antibody, respectively (ii) a spectrum red labeled probe speci®c for chromosome 3 (Vysis). The red LAZ3 and green RhoH/TTF speci®c signals were observed on the normal chromosomes 3 and 4 (a) and the yellow fusion signal (arrow), which resulted of the splitting of the RhoH/TTF probe signal, was observed on the derivative chromosome 3 of VAL cell line (b), patient 1 (c) and patient 2 (d) metaphases
Oncogene Nonrandom 4p13 rearrangement of the RhoH/TTF gene C Preudhomme et al t(3;4), among them patient 2 (Figure 2 part II, d), which could not be studied by RT ± PCR. A lack of metaphase spreads from patient 4 hindered the demonstration of the same gene fusion in this case. Because, in follicular lymphoma t(14;18) is considered a primary event and because, in one of the NHL cases, t(3;4) (q27;p13) was only found in some of the mitoses examined, this translocation with disruption of the RhoH/TTF gene was probably a secondary event (Daudignon et al., 1999) . Because two of the patients rapidly died and because all of the patients presented also a chromosome 6 abnormality, which is known to be of bad prognosis, it is dicult to evaluate the prognosis value of the t(3;4). This might be studied on a larger cohort of patients.
The RhoH/TTF partner gene in the t(3;4) recurrent abnormality was shown to be the LAZ3 gene. As often hypothesized or even demonstrated in many cases involving this gene at band 3q27, the critical molecular consequence of such translocations would be the substitution of the 5' regulatory elements of LAZ3 by heterologous regulatory sequences on the partner chromosome (Dallery et al., 1995; GalieÁ gue-Zouitina et al., 1996; Akasaka et al., 1997) , which would lead to transcriptional deregulation of the gene Chen et al., 1998) . For example, we previously cloned C Figure 3 RT ± PCR analysis of two patients with t(3;4). The RT ± PCR experiments were performed for patients 1 and 3 and on Raji and VAL cell lines, as negative and positive controls, respectively. (a): schematic representation of the dierent TTF-LAZ3 and LAZ3-TTF fusion transcripts, with the table of results indicating the sizes of the dierent PCR products. The hatched and white boxes indicate RhoH/TTF and LAZ3 exons, respectively. Assays no I or II were performed to search for the TTF-LAZ3 fusion transcripts, by priming with RhoH/TTF exon 1a or 1b, respectively, and within LAZ3 exon 3. Assay no III was made to search for the reciprocal LAZ3-TTF fusion transcript, by priming within LAZ3 exon 1a and RhoH/TTF exon 2. Assay no I gave rise to two PCR products, containing or not RhoH/TTF exon 1b (product 2: 350 bp or product 1: 150 bp). Assay no II was performed to con®rm the junction of RhoH/TTF exon 1b to LAZ3 exon 2 observed in assay no I. This PCR reaction did not allow to distinguish between exon 1b alone or exons (1a-1b) together. (b): electrophoretic migration of the three dierent RT ± PCR assays. 0: control (no RNA); R: Raji cell line, 1: patient 1; V: VAL cell line; 3: patient 3. (c): sequences of the fusion junctions of the RT ± PCR products in the VAL cell line and in both patients, showing exact splice junctions between RhoH/TTF exons 1a or 1b and LAZ3 exon 2, or between LAZ3 exon 1a and RhoH exon 2 (reciprocal fusion transcript). The splice junctions are underlined t(3;4) (Dallery et al., 1995) , t(3;11) (GalieÁ gue-Zouitina et al., 1996), and t(3;13) (GalieÁ gue-Zouitina et al., 1999) chromosome translocations which involve at band 3q27 the LAZ3 gene; in all cases there was no formation of fusion proteins as a consequence of the partner genes rearrangements, but a promoter substitution, which may potentially deregulate the expression of these genes. We have here analysed the RhoH/TTF and LAZ3 fusion transcripts in two patients (1 and 3, respectively) and in patient 1, we have suggested a deregulated expression of both LAZ3 and RhoH/TTF genes, by promoter exchange. Indeed, in this case, two fusion products of dierent origin were observed: (i) a TTF(1a)-LAZ3 fusion transcript, emerging from the derivative 3 allele, and (ii) a reciprocal LAZ3-TTF fusion transcript, emerging from the derivative 4 allele (Figure 3) . Such a substitution, placing each gene under the control of the partner gene promoter, may lead to the deregulation of both gene expressions in this patient, like in the VAL cell line, where the same fusion transcripts were detected. In patient 3 in contrast, the LAZ3 gene alone seemed to be deregulated by promoter exchange (in this case the reciprocal fusion transcript was not observed). In this patient as in the VAL cell line, two TTF-LAZ3 fusion transcripts were detected, showing an alternative fusion of LAZ3 exon 2 to either RhoH/TTF exon 1a alone, or exons 1a-1b together. In patient 1 in contrast, due to the position of the breakpoint within the RhoH/TTF gene, a splice junction was observed between only RhoH/TTF exon 1a (but not 1b) and LAZ3 exon 2. This heterogeneity of the TTF-LAZ3 fusion transcripts was checked in both patients using additional primer pairs (see Table 2 , controls), con®rming the results (data not shown). The exact function of the two ®rst non coding exons of the RhoH/TTF gene is not known at this time, we only know that the same alternative splicing between 1a and 1b exons occurs in the normal RhoH/TTF transcripts (data not shown). Such a splicing may lead here in the patients to dierent LAZ3 gene deregulation events between the two cases. The Northern blot analysis (Figure 4 ) made on these two patients and cell line VAL was in agreement with the RT ± PCR data. This indicates that among three dierent t(3;4) cases (patients 1, 3 and VAL cell line), there was a variability in the expression of LAZ3 and RhoH/TTF genes, emerging from both rearranged chromosomes 3 and 4, which may lead to variable deregulation events concerning these genes. We very recently described the rearrangement of both LAZ3 and LCP1 (L-Plastin) genes, at bands 3q27 and 13q14, in two cases of B-NHL with t(3;13)(q27;q14), and we analysed the fusion transcripts in these two cases (GalieÁ gue-Zouitina et al., 1999). As observed here in the t(3;4), there was a discrepancy between the two cases: both LAZ3 and LCP1 fusion transcripts were detected in one case, but only the LAZ3 fusion transcript was noted in the other case.
In patient 5 with multiple myeloma (MM), t(4;14) was the only chromosome abnormality. Therefore, RhoH/TTF is not only the LAZ3 partner translocation in the t(3;4), but might be perhaps deregulated by other regions of other chromosomes, in this case the 14q32 region. We have shown here by FISH that the heavy chain immunoglobulin gene was disrupted in this patient 5 ( Figure 5) . We searched for an IgH-RhoH/ TTF fusion transcript by conducing 5' Race-PCR experiments (Marathon cDNA kit, Clontech), using a primer from RhoH/TTF exon 2 and the anchor primer, without success (data not shown). This could be due to the very low representation of such a transcript, or rather to its absence. We also checked the expression of RhoH/TTF in patient 5, by comparative Northern blot analysis of various plasma cell lines (with low RhoH/ TTF expression) and of cells from patient 5. A notable RhoH/TTF expression was observed in patient 5, but was dicult to interpret, due to the contaminant RhoH/ TTF expression emerging from the normal lymphocyte cells in this t(4;14) sample (not shown). Separating the tumor cells from the contaminating normal cells would have been of interest in this case, but was impossible to do here, due to a lack of material.
MM is frequently associated with chromosome abnormalities, especially translocations involving 14q32 and a variety of other chromosomes, including the short arm of chromosome 4 (Zandecki et al., 1996; Bergsagel et al., 1996) . One case of t(4;14) was already described in MM, but with a breakpoint in the 4p16.3 region, implicating the FGFR3 gene, which was shown to be deregulated by juxtaposition to the IgH gene, in this observation (Chesi et al., 1997) . Another recurrent chromosome abnormality involving the short arm of chromosome 4 has been recently described, as a dicentric (4;17) chromosome with 4p11-pter/17p11-pter deletion (Callet-Bauchu et al., 1996) . This abnormality has been observed in three patients with chronic lymphocytic leukemia (CLL). Due to the orientation of the RhoH/TTF gene on chromosome 4p13: telomere-5'-3'-centromere (Dallery-Prudhomme et al., 1997) , we checked by FISH eleven CLL patients, ®ve of them presenting a dic (4;17), to search for a RhoH/ TTF disruption in these cases, and to determine if the gene could be deregulated by a promoter of the 17p region. Our results indicated the absence of involvement of the RhoH/TTF gene in CLL (data not shown).
The RhoH/TTF gene encodes a small GTP-binding protein belonging to the Rho subfamily (Dallery et al., 1995) . Almost all Rho-like members are involved in the organization of actin cytoskeleton (Hall, 1998) . These GTPases are key elements in signal-transduction pathways controlling the formation of lamellipodia, stress ®bers, and ®lopodia, respectively induced by growth Figure 4 Northern blot analysis in two patients with t(3;4). Expression was analysed in Raji (R) and VAL (V) cell lines, respectively as negative and positive controls, and in RNAs from patients 1 and 3. Total RNA samples (20 mg) were hybridized with the 1.4 kb cDNA probe (Dallery et al., 1995) . Actin expression was tested in the same samples to evaluate both quantity and quality of RNA samples Oncogene Nonrandom 4p13 rearrangement of the RhoH/TTF gene C Preudhomme et al factors or oncogenic Ras (Nobes and Hall, 1995) . It has been reported that three members of this Rho-like proteins subfamily, Rac-1, RhoA, and Cdc42 have a role in Ras (or cellular) transformation (Qiu et al., 1995a,b; . Indeed, the expression of a constitutively activated Rac-1 protein is sucient to cause malignant transformation and Rac activity is required for Ras transformation. The Tiam-1 protein, a GDPdissociation stimulator (GDS) of the Rac-1 protein (Habets et al., 1994) was shown to be involved in membrane ruing and invasion (Michiels et al., 1995) and thus, the Tiam1-Rac signaling pathway could be operating in the invasion and metastasis of tumor cells. More recently, it was shown that the Bcr-Abl-mediated leukemogenesis requires the activity of the Rac-1 protein (Skorski et al., 1998).
According to our data, an involvement of the small G protein encoding gene RhoH/TTF in the tumorigenic process, as a LAZ3 partner, might be considered. To address the role of RhoH/TTF in neoplastic transformation, we are searching for additional rearrangements and activating mutations of this gene in hematopoietic malignancies, and are analysing its transforming potential in dierent cellular systems. 4;14) . (a) the probes used were: (i) two a-satellite probes, a spectrum orange labeled probe speci®c for chromosome 4 and a texas red labeled probe speci®c for chromosomes 14/22 (Oncor) (ii) a biotin-labeled RhoH/ TTF DNA probe, detected with FITC-avidin (white arrows). A green RhoH/TTF signal (two spots) was observed on normal chromosome 4, and also observed on both derivative chromosomes 4 and 14, split by the translocation. (b) probes: a spectrum orange labeled painting probe speci®c for the long arm of chromosome 14 (14q), and the same biotin-labeled RhoH/TTF probe. We could see the green RhoH/TTF signal on the normal and derivative chromosomes 4 and on the derivative chromosome 14 (white arrows). (c) probes: a spectrum orange labeled probe speci®c for chromosome 4 (Vysis), and a biotin-labeled IgH (cos 3/64 and cos Ig6) cosmid probe, detected with FITC-avidin (white arrows). Two green signals were visualized, one of them normally located on the 14q32 region, and the other on the derivative chromosome 4, near the centromere (red signal). (d) probes: a spectrum orange labeled probe speci®c for chromosome 4 (Vysis), and a biotin-labeled IgH (cos 3/64, cos Ig6, and cos Ig10) cosmid probe, detected with FITC-avidin (white arrows). Three green signals were observed, one of them on the derivative chromosome 4, the two others on normal and derivative chromosome 14
North (Daudignon et al., 1999 ; in this work, patient 2 was inversely referred to as patient 1 here, patient 3 to as patient 2, patient 4 to as patient 3, and patient 1 to as patient 4). Patient 5 with t(4;14), a female aged 62, was followed ®rst for monoclonal gammapathy of undetermined signi®cance (MGUS), progressively evolving into multiple myeloma. BM examination in 1996 revealed 40% of plasma cells with abnormal karyotype. Cytogenetic analyses were performed in all cases after a 24 h culture. Bone marrow (BM) cells (cases 1, 5) or lymph node (LN) cells (cases 2, 3, 4) were cultivated in RPMI 1640 supplemented with 20% fetal calf serum or in Chang medium (Clini Sciences, Irvine Scienti®c Inc, Santa Ana, CA, USA). Both cultures were karyotyped and interpreted after Gbanding or/and R-banding. Chromosome abnormalities were described according to International System for Human Cytogenetic Nomenclature (ISCN, 1991) .
Metaphase spreads obtained for cytogenetic analysis were also used in FISH analysis.
Cell lines
VAL and Raji cell lines were used as positive and negative controls in the RT ± PCR and Northern blot experiments. The VAL cell line has already been described (Dallery et al., 1995) as a stable continuous B cell line bearing a t(8;14;18)(q24;q32;q21) and a t(3;4)(q27;p11). The Raji B cell line was purchased from American Tissue Culture Collection (ATCC). Both cell lines were maintained in RPMI medium supplemented with 10% calf serum. Metaphases of the VAL cell line and normal metaphases (Vysis, Woodcreek, IL, USA) were used as positive and negative controls, respectively, in FISH analysis.
Probes
FISH probes
Centromeric probes speci®c for chromosomes 3, 4 and a painting probe for chromosome 14q were kindly provided by Vysis (Woodcreek, IL, USA). The centromeric probe speci®c for chromosomes 14/22 was purchased from Oncor, Inc, (Gaithersburg, MD, USA). Three clones of the RhoH/TTF locus were combined for a RhoH/TTF FISH probe (Figure 1) , as previously used (Dallery-Prudhomme et al., 1997) except that one clone, l2V20, was replaced by the l2V18 clone, to obtain a total overlap of approximately 60 kb, instead of 50 kb, as previously reported. The probe was labeled by nicktranslation with biotin-14-dUTP (Gibco-BRL). This probe previously allowed us to obtain a good signal in FISH, using detection of the signal with¯uorescein isothiocyanate (FITC)-avidin (Dallery-Prudhomme et al., 1997) . The LAZ3 probe (a 7 kb genomic fragment containing exons 4 to 8 of the gene, subcloned in bluescript pKS) was labeled by nick-translation with digoxygenine-11 dUTP (Boehringer, Mannheim). The detection of the signal was performed using antidigoxygenine rhodamine labeled antibody. The probe was ®rst checked on normal metaphase spreads: a speci®c signal was observed on the telomeric part of the long arm of chromosome 3 (Figure 2 , part II, a). A mix of the two previously described RhoH/TTF and LAZ3 probes was cohybridized on dierent metaphase spreads for the double colour fusion assay. Three chromosome 14q32 cosmid clones were used, located, from telomere to centromere, in the JH-Cm-Cd, Cg3 and Ca2-Ce regions respectively, within the IgH gene (cos 3/64, cos Ig6, and cos Ig10). Cos 3/64, cos Ig6 and cos Ig10 were generous gifts from M Dyer, L Coignet (Royal Marsden Hospital, Sutton, UK) and T Rabbitts (MRC Laboratory of Molecular Biology, Cambridge, UK), respectively. The three probes were labeled by nick translation with biotin-14 dUTP, and prior to their use on metaphase spreads from patient 5, each cosmid probe was checked on normal metaphases (Vysis): all three cosmid probes gave clear and speci®c signals on the sub-telomeric region of the long arm of chromosome 14 (not shown).
cDNA probe
The RhoH/TTF cDNA probe used in Northern blot experiments was a 1.4 kb cDNA fragment containing exons 1b and 2 (Dallery et al., 1995) .
FISH analysis
The RhoH/TTF probe was ®rst cohybridized with the centromeric probes of chromosomes 3 and 4 in patients with t(3;4) and with the centromeric probes of chromosomes 4 and 14/22 (or a chromosome 14q painting probe) in the case of the patient with t(4;14), to metaphase spreads of lymphoma or myeloma cells of the dierent patient samples. RhoH/TTF and IgH DNA hybridizations were detected with FITCconjugated avidin, as previously reported (Dallery-Prudhomme et al., 1997) . Second, a double colour fusion FISH fusion assay was performed using cohybridization of a mix of the RhoH/TTF and LAZ3 intragenic probes, to demonstrate the fusion of both genes in three patients with t(3;4) (patients 1, 2 and 3). Metaphase spreads were counterstained with 4'6-diamidino-2-phenylindole dihydrochloride (DAPI) diluted in antifade medium (Vectashield), and analysed using Quips Software (Vysis). The centromeric probes were labeled as follows: spectrum orange for chromosome 4 and chromosome 14q painting probe; texas red for chromosomes 14/22 centromeric probes; spectrum green for chromosome 3 centromeric probe. Dual colour FISH assay was also performed with a spectrum orange centromeric probe of chromosome 4 and biotin-labeled IgH cosmids probe, on metaphase spreads of myeloma cells from patient 5.
RNA analysis
In patients with sucient material (patients 1, 3, 5), RNA was prepared. Total cellular RNA was extracted from patients 1, 5 (from bone-marrow cells) and 3 (from tumor lymph node tissue), using guanidinium isothiocyanate and centrifugation through cesium chloride (Chirgwin et al., 1979) .
RT ± PCR analysis
RT ± PCR method was used to detect RhoH/TTF and LAZ3/ BCL6 transcripts from the RNAs of patients 1 and 3. We also used the VAL cell line RNA as a positive control and the Raji cell line RNA as a negative control in the analysis of the fusion transcripts. cDNAs were obtained by randompriming of 15 mg of total RNA with 125 units of M-MLV reverse transcriptase (Gibco-BRL). From these templates, we tried to amplify both fusion transcripts expected from the derivative chromosomes 3 and 4 and also both normal RhoH/ TTF and LAZ3/BCL6 transcripts. The dierent primer's pairs used are described in Table 2 .
Northern blot analysis
Equal amounts of RNA (20 mg) were size fractionated on a denaturing formaldehyde 1% agarose gel and blotted onto nitro-nylon membrane hybond C (Amersham, Arlington Heights, IL, USA). After Northern blotting, the ®lters were hybridized and washed as previously described (Kerckaert et al., 1993; Dallery et al., 1995) .
